MaxEPA Interactions
There are 76 drugs known to interact with MaxEPA (omega-3 polyunsaturated fatty acids), along with 2 disease interactions. Of the total drug interactions, 76 are moderate.
- View all 76 medications that may interact with MaxEPA
- View MaxEPA disease interactions (2)
Most frequently checked interactions
View interaction reports for MaxEPA (omega-3 polyunsaturated fatty acids) and the medicines listed below.
- Adderall XR (amphetamine / dextroamphetamine)
- allopurinol
- amlodipine
- aspirin
- atorvastatin
- buspirone
- CoQ10 (ubiquinone)
- Cymbalta (duloxetine)
- diazepam
- diphenhydramine
- doxycycline
- fenofibrate
- finasteride
- fluoxetine
- fluticasone nasal
- gabapentin
- gemfibrozil
- Ginkgo Biloba (ginkgo)
- ibuprofen
- Inderal (propranolol)
- indomethacin
- losartan
- magnesium citrate
- meloxicam
- montelukast
- multivitamin with minerals
- mupirocin topical
- Nexium (esomeprazole)
- Norco (acetaminophen / hydrocodone)
- tamsulosin
MaxEPA disease interactions
There are 2 disease interactions with MaxEPA (omega-3 polyunsaturated fatty acids) which include:
Report options
QR code containing a link to this page
More about MaxEPA (omega-3 polyunsaturated fatty acids)
- MaxEPA consumer information
- Compare alternatives
- Drug images
- Side effects
- Dosage information
- During pregnancy
- Drug class: nutraceutical products
- En español
Related treatment guides
Drug Interaction Classification
| Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
| Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
| Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
| No interaction information available. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
